-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US98973P1012 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | 6M |
|---|---|
| Beta | -1.13 |
| PE Ratio | None |
| Target Price | 1.75 |
| Dividend Yield | None |
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. The company develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. It also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for TCRT using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026